Overview

Continuous Administration of Oral Contraceptive, Primary Dysmenorrhea

Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
The primary hypothesis is that continuous administration of an OCP (CCOCP regimen) will result in more pain relief than a traditional 21/7 administration in primary dysmenorrhea (PD) patients.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Milton S. Hershey Medical Center
Treatments:
Contraceptive Agents
Contraceptives, Oral
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Estradiol valerate
Ethinyl Estradiol
Gestodene
Polyestradiol phosphate